American International Group, Inc. Gilead Sciences, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $149,960 - $182,872	-2,095 Reduced 0.52%	400,989 $29.4 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $729,109 - $826,828	-9,951 Reduced 2.41%	403,084 $32.7 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $875,893 - $955,616	11,846 Added 2.95%	413,035 $31 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $410,986 - $468,786	5,407 Added 1.37%	401,189 $30.9 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $40,046 - $45,625	-518 Reduced 0.13%	395,782 $32.8 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $551,033 - $791,093	-8,842 Reduced 2.18%	396,300 $34 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $473,700 - $541,087	-7,956 Reduced 1.93%	405,142 $25 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $555,208 - $625,331	-9,619 Reduced 2.28%	413,098 $25.5 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $880,036 - $1.1 Million	-15,194 Reduced 3.47%	422,717 $25.1 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $70,070 - $79,531	-1,080 Reduced 0.25%	437,911 $31.8 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $451,018 - $486,598	-6,663 Reduced 1.5%	438,991 $30.7 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $315,255 - $344,461	-4,967 Reduced 1.1%	445,654 $30.7 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $5.7 Million - $6.51 Million	-95,077 Reduced 17.42%	450,621 $29.1 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $123 Million - $140 Million	-2,174,563 Reduced 79.94%	545,698 $31.8 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $25.6 Million - $32.2 Million	-413,023 Reduced 13.18%	2,720,261 $172 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $35.4 Million - $41 Million	-488,668 Reduced 13.49%	3,133,284 $241 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $98 Million - $125 Million	-1,564,161 Reduced 30.16%	3,621,952 $271 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $4.8 Million - $5.28 Million	-77,916 Reduced 1.48%	5,186,113 $337 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $13.7 Million - $15.1 Million	-218,497 Reduced 3.99%	5,264,029 $334 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $21.8 Million - $24.4 Million	-351,809 Reduced 6.03%	5,482,526 $370 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $16.1 Million - $18 Million	-257,329 Reduced 4.22%	5,834,335 $379 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $2.91 Million - $3.79 Million	-48,018 Reduced 0.78%	6,091,664 $381 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $13 Million - $14.4 Million	-182,990 Reduced 2.89%	6,139,682 $474 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $15.8 Million - $18.5 Million	-243,855 Reduced 3.71%	6,322,672 $448 Million
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $1.43 Million - $1.74 Million	-19,577 Reduced 0.3%	6,566,527 $495 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $11.8 Million - $13.9 Million	165,830 Added 2.58%	6,586,104 $472 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $463 Million - $549 Million	6,420,274	6,420,274 $520 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.64 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.38 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.05 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.96 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account